The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 23, 2021

Filed:

Sep. 28, 2018
Applicant:

Trustees of Tufts College, Medford, MA (US);

Inventors:

Andrew Camilli, Sharon, MA (US);

Lynne Cairns, Somerville, MA (US);

Minmin Yen, Cambridge, MA (US);

Assignee:

TRUSTEES OF TUFTS COLLEGE, Medford, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/76 (2015.01); C12N 7/00 (2006.01); C12N 7/02 (2006.01); A61P 31/04 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 35/76 (2013.01); A61K 9/0053 (2013.01); A61K 45/06 (2013.01); A61P 31/04 (2018.01); C12N 7/00 (2013.01); C12N 7/02 (2013.01); C12N 2795/00021 (2013.01); C12N 2795/00032 (2013.01); Y02A 50/30 (2018.01);
Abstract

Compositions and methods are provided for preventing, ameliorating, or treating a disease caused by a species of bacterial genus, for example, cholera caused by, the compositions containing two or more strains of lytic bacteriophage that infect and killcells. The bacteriophage are virulent, which replicate intracellularly and lyse and kill the bacteria. Use of two or more strains in a single treatment, as a result of a rate of mutation of the bacteria to simultaneous resistance to all of the bacteriophage to be so low as to be negligible, reduces appearance of phage-resistant bacteria to statistical negligibility. Normal human microbial flora species were not affected. In alternative embodiments of the method and the composition, antibiotic agents or other treatment agents can be administered with a cocktail of the plurality of bacteriophage strains.


Find Patent Forward Citations

Loading…